BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

8 articles for TW Moore

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer.EBI
University of Illinois At Chicago
Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators.EBI
University of Illinois At Chicago
Monocarbonyl curcumin analogues: heterocyclic pleiotropic kinase inhibitors that mediate anticancer properties.EBI
Emory University
Peptide-Drug Conjugates: An Emerging Direction for the Next Generation of Peptide Therapeutics.EBI
University of Illinois Chicago
Synthesis and Evaluation of Noncovalent Naphthalene-Based KEAP1-NRF2 Inhibitors.EBI
University of Illinois At Chicago
Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway.EBI
University of Illinois At Chicago
Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability.EBI
TBA
Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors.EBI
University of Illinois At Chicago